Candida auris: CDC warns of risk of new, drug resistant strain in US
BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1880 (Published 26 July 2021) Cite this as: BMJ 2021;374:n1880- Janice Hopkins Tanne
- New York
Outbreaks have been reported in the US of transmissible Candida auris fungal infections that have been found to be resistant to drugs and difficult to treat. In a report published on 22 July the Centers for Disease Control and Prevention said that two clusters of cases had been reported in Washington, DC, and in Texas.1
C auris is a different organism from the “black fungus” reported among covid-19 patients in India.
“These two simultaneous, independent clusters of pan- or echinocandin resistant C auris cases in patients with overlapping inpatient health care exposures and without previous echinocandin use provide the first evidence suggesting that pan- or echinocandin-resistant C auris strains might have been transmitted in US health care settings . …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.